Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |